Saba Capital Management, L.P. sold HQL
February 3, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 1,846 shares of Abrdn Life Sciences Investors at $14.03 per share, a transaction worth $25.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,846
Price
$14.03
Total value
$25.9K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 3, 2025
Filing dateFebruary 5, 2025
Shares owned after3,379,525
OwnershipIndirect
10b5-1 planNo
AmendedNo